- Home
- AOD vs VALN Comparison
AOD vs VALN Comparison
Compare AOD & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AOD
- VALN
- Stock Information
- Founded
- AOD 2006
- VALN 2012
- Country
- AOD United Kingdom
- VALN France
- Employees
- AOD N/A
- VALN N/A
- Industry
- AOD Investment Managers
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AOD Finance
- VALN Health Care
- Exchange
- AOD Nasdaq
- VALN Nasdaq
- Market Cap
- AOD 1.0B
- VALN 820.0M
- IPO Year
- AOD N/A
- VALN 2021
- Fundamental
- Price
- AOD $9.20
- VALN $8.73
- Analyst Decision
- AOD
- VALN Strong Buy
- Analyst Count
- AOD 0
- VALN 4
- Target Price
- AOD N/A
- VALN $15.75
- AVG Volume (30 Days)
- AOD 423.5K
- VALN 29.3K
- Earning Date
- AOD 01-01-0001
- VALN 11-20-2025
- Dividend Yield
- AOD 12.95%
- VALN N/A
- EPS Growth
- AOD 213.63
- VALN N/A
- EPS
- AOD 1.93
- VALN N/A
- Revenue
- AOD $72,962,082.00
- VALN $230,566,060.00
- Revenue This Year
- AOD N/A
- VALN $6.86
- Revenue Next Year
- AOD N/A
- VALN $11.85
- P/E Ratio
- AOD $4.44
- VALN N/A
- Revenue Growth
- AOD N/A
- VALN 25.47
- 52 Week Low
- AOD $6.99
- VALN $3.62
- 52 Week High
- AOD $9.14
- VALN $12.25
- Technical
- Relative Strength Index (RSI)
- AOD 31.97
- VALN 34.00
- Support Level
- AOD $9.49
- VALN $9.01
- Resistance Level
- AOD $9.66
- VALN $9.28
- Average True Range (ATR)
- AOD 0.12
- VALN 0.22
- MACD
- AOD -0.05
- VALN -0.09
- Stochastic Oscillator
- AOD 10.55
- VALN 22.97
About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.